Pharma and Healthcare | Reports and Data: May 2019

Tuesday, May 28, 2019

Intravenous Immunoglobulin (IVIG) Market Leading Player, Application & Forecast To 2026

The rapid increase in neurological disorders, increase in geriatric population, and continuous increase in the number of patients are fueling the market growth.

Market Size – USD 9.43 Billion in 2018, Market Growth - CAGR of 6.3%, Market Trends – Rise in autoimmune diseases.

The Global Intravenous Immunoglobulin (IVIG) Market is forecast to reach USD 15.67 Billion by 2026, according to a new report by Reports and Data.

Immunoglobulin refers to the breakdown of blood plasma that contains antibody. It is a procedure that is undertaken intravenously. It is a treatment of choice for patients with antibody deficiency. Immunoglobulins are highly complex entities, and they are very specific in their action. They are obtained from blood by fractionation process and purified for nontherapeutic and therapeutic applications. Different classes of immunoglobulin such as IgA, IgG, and IgM are used for the treatment of various neurological and immunological diseases.

Primary factors for the growth of the market are an increase in the geriatric population, an increase in the number of hemophilic patients, enhancement in technology related to immunoglobulin production, and better purification techniques.

North America dominated the market of Intravenous Immunoglobulin (IVIG). Increase in the level of awareness of these procedures and preference of clinicians to adopt these techniques is boosting the growth of the market in this region. Investment in the healthcare system by the government is also propelling the growth of the market.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-intravenous-immunoglobulin-ivig-market

Further key findings from the report suggest

Human IgG is expressed in the surface of mature B cells and is the most prevalent serum among all the other Immunoglobulin. It held the largest market share of 31% in the year 2018.
Immunoglobulin via intravenous procedure is majorly done in hospitals. It held a market share of 43% in the year 2018.
The market is segmented into hospital pharmacy and specialty pharmacy based on the distribution channel.
Hospital pharmacy is forecast to hold a market share of 58% in the year 2026 with a higher CAGR of 6.5% during the forecast period.
Hypogammaglobulinemia is an immune disorder that reduces all types of gamma globulins, along with antibodies that help the body fight infection.
It held the largest market share of 19% in the year 2018. The disease can be from birth, can flare up due to any medication or maybe due to kidney or gastrointestinal condition, severe burns, or cancer.
Immunodeficiency disease is forecasted to grow with a CAGR of 7.3% during the forecast period. Examples of it can be an infection (HIV), medications (chemotherapy or systemic steroids), and severe burns or malnutrition.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare disorder where peripheral nerves and nerve roots are inflamed, and myelin sheath over the nerves is destroyed.
CIDP is growing swiftly with time. It is forecasted to have a CAGR of 6.3% during the forecast period. The disease affects males twice as often as females.
Kawasaki disease is forecasted to hold a market share of 14% in the year 2026. It is a rare childhood disease that inflames the blood vessels of the body.
People with the Immune Thrombocytopenic Purpura ITP disease have too few platelets in the blood. It is forecasted to have a CAGR of 8.1% during the forecast period.
For the purpose of this report, Reports and Data have segmented into the global Intravenous Immunoglobulin (IVIG) Market on the basis of Type, Application, End Users, Distribution Channel, and Region:

Type Outlook (Revenue, USD Billion; 2016-2026)

Application Outlook (Revenue, USD Billion; 2016-2026)

Hypogammaglobulinemia
Immunodeficiency Diseases
Congenital AIDS
Chronic Inflammatory Demyelinating Polyneuropathy
Myasthenia Gravis
Multifocal Motor Neuropathy
ITP
Guillain-Barre syndrome
Kawasaki Diseases
Others

End Users Outlook (Revenue, USD Billion; 2016-2026)

Hospitals
Clinics
Homecare
Others

Distribution Channel Outlook (Revenue, USD Billion; 2016-2026)

Hospital Pharmacy
Specialty Pharmacy

Regional Outlook (Revenue, USD Billion; 2016-2026)

North America
- U.S.
Europe
- UK
- France
Asia Pacific
- China
- India
- Japan
MEA
Latin America

Brazil

Request for sample of this premium report at: https://www.reportsanddata.com/sample-enquiry-form/1442

About Us:
We are a boutique market intelligence and strategic consulting firm dedicated to make an meaningful impact on businesses across the globe. Our stellar estimation and forecasting models have earned recognition across majority of the business forum across the globe. Our services are arrayed over diverse sectors and industries looking to expand in alternative regions and products.

Contact Us:
John Watson
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

Electroceuticals/Bioelectric Medicine Market Analysis, Growth, Trends, Challenges with Forecast To 2026

High number of diseases due to rise in geriatric population, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario for development of Electroceuticals devices are key factors contributing to high CAGR of Bioelectric Medicine during forecast period.

Market Size – USD 20.00 Billion in 2018, Market Growth - CAGR of 8.5%. Market Trends – Product launches and research for Anti-Snoring devices and surgical instruments.

According to the current analysis of Reports and Data, the global Electroceuticals/Bioelectric market was valued at USD 20.00 Billion in 2018 and is expected to reach USD 38.13 Billion by year 2026, at a CAGR of 8.5%.

According to a study conducted by World Health Organisation in 2017, four major chronic diseases including cardiovascular diseases, cancers, diabetes, chronic respiratory diseases and diabetes were the major cause for 80% of all premature deaths.

Bioelectric medicine or Electroceuticals devices indicates the usage of devices instead of drugs, are safe to block, record and stimulate neural signals to cure from chronic disorders. They are invasive and non-invasive in nature which are held against the skin or implanted in nerve to restore the healthy condition of the patient without the complicated side of pharmaceutical agents. They treat diseases by the implication of devices which combine bioengineering, neuroscience, molecular medicines and electronics for the regulation of biological process. The bioelectric therapy also prompts the body to produce endorphins which helps to relieve pain in the body of the patients. So, usually there’s an inflammation which is the central phenomenon in all diseases starting from cancer to diabetes and secondly, this inflammation can be controlled through electrically stimulating vagus nerve. Electroceutical devices are used for the treatment of epilepsy, cardiovascular diseases, cancer, paralysis, rheumatoid arthritis and diabetes, etc. Key recent developments in the field of bioelectric medicine pharmaceutical include production of different electroceuticals devices. For instance, in April 2017, FDA approved a device called GammaCore launched by ElectroCore that transmits a mild electrical simulation to the vagus nerve through the skin, resulting in a reduction of pain to treat cluster headaches, a rare form of headache that affects mostly men.

Rising number of disorders in geriatric population, immense funding by the companies and the government to cure these diseases without the consumption of drugs are the main factors which are boosting the growth of Electroceuticals/Bioelectric medicine market. Increasing research and development in bioelectric medicals with rising number of organizations investing for development of bioelectric medicines are primary driving factors for the growth of Electroceuticals/Bioelectric medicine market. For instance, in May 2014, FDA approved Inspire Upper Airway Stimulation (UAS) Therapy of Inspire Medical Systems, Inc. for Obstructive Sleep Apnea for the patients who are not able to use Continuous Positive Airway Pressure (CPAP) which is a fully implanted neurostimulation device.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-electroceuticals-bioelectric-medicine-market

Further key findings from the report suggest:

Electroceuticals/Bioelectric Medicine market is fastest growing at a CAGR of 6% in Asia Pacific due to rising prevalence of population diagnosed with chronic disorders, obesity and old age and even huge positive R&D outcomes
The market for chronic pain segment is projected to have the highest CAGR during the forecasted period because of the prevalence of issues like diabetes, unhealthy lifestyle, high or low blood pressure and others which in turn leads to chronic diseases
Europe is the second largest region with a share of 31.0 % due to the high cases of mergers and acquisitions and advancements in R&D
Cardiac Pacemakers is accounted to be the second leading segment which is valued at USD 5411.7 million due to increasing number of patients with cardiac disorders and a huge demand and supply of implantable cardiac pacemakers across the regions
Hospitals segment has dominated the market in 2018 and will continue to do the same in the forecasted years

Segments covered in the report:

For the purpose of the study, this Reports and Data has segmented the Global Electroceuticals/Bioelectric Medicine Market on the basis of product type, devices type, application, end user and the regional outlook:

Product Type (Revenue, USD Million; 2016–2026)

Cardiac Pacemakers
Implantable Cardioverter Defibrillators
Stimulators
- Spinal cord
- Deep brain
- Vagus Nerve
- Sacral Nerve
Transcutaneous Electrical Nerve
Implants
- Retinal
- Cochlear
Others

Devices Type (Revenue, USD Million; 2016–2026)

Implantable Electroceutical Devices
Non-Invasive Electroceutical Devices

Application (Revenue, USD Million; 2016–2026)

Pain Management
Depression
Epilepsy
Arrhythmia
Tremor
Parkinson’s Disease
Sensorineural Hearing Loss
Urinary and Fecal Incontinence
Menstrual migraine
Retinitis Pigmentosa
Spinal Cord Injury
Others

End User (Revenue, USD Million; 2016–2026)

Hospitals
Ambulatory Surgical Centres
Speciality Clinics
Homecare Centres
Individual Users
Others

Regional Outlook: (Revenue, USD Million; 2016–2026)

North America
- U.S.
- Canada
Europe
- Germany
- UK
- Spain
- France
- Italy
- Rest of Europe

Asia Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific

Latin America
- Brazil
- Mexico
Middle East and Africa (MEA)

Request for sample of this premium report at: https://www.reportsanddata.com/sample-enquiry-form/1447

Kidney Function Test Market Trends, Emerging Growth Factors And Forecast 2026

The alerting rise in aging and geriatric population which leads to the high prevalence of kidney diseases, obesity and cardiovascular diseases has been driving the market into growth. The increase in investment levels lead to technological and diagnostic advancements which further instigates the market to growth and development.

Market size- USD 656.6 Million in 2018, Market Growth- 6.2% CAGR, Market Trends- Innovation of new forms of diagnosis and preventive measures, acquisitions and investments in the emerging markets for various technological advances and treatment.

According to a study and analysis by Reports and Data, the global Kidney Function Test market was valued at USD 656.6 Million in 2018 and is expected to be USD 1061.0 million by the end of the forecasting period of 2026, at a CAGR of 6.2%. The market is witnessing high growth due to increasing number of Kidney testing functions for patients suffering from kidney malfunctions mainly due to changing lifestyles. The kidney is an essential organ which refines the fluids in our body before distributing them and a malfunction can lead to various stages of cancer and chronic disease.

Other factors driving the growth of this market includes rising level of awareness among the public about the several kidneys disease, hypertension and cardiovascular activities. The number of incidences of renal fibrosis has increased at an alarming rate and has been responsible for the growth of this market restrained by the high cost of development, maintenance and innovations.

Among all the regions, Asia-Pacific is the fastest growing one due to the increasing number of competitors in China, Japan and India with an aging population suffering from chronic diseases and diabetes. As per a study conducted by the Asian Development Bank (ADB), the geriatric population in Asia is estimated to reach 923 million by 2050 providing a favourable background for the market growth in the Asia Pacific region. On the other hand, Middle East and Africa has the least share in the global kidney function test market due to the stringent government policies, low gross national income and poor health planning and therapeutic measures. The market is expected to witness a rapid growth mainly because of the awareness of advances in preventive measures, increased hypertension, smoking, and high cholesterol which will contribute to the market growth.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-kidney-function-test-market

Further key findings from the report suggest

As per the Centre for Disease Control and Prevention 44% of the diabetic patients suffered from End-Stage Renal Disease in U.S. in 2017 as diabetes damage the blood vessels of kidneys leading to an improper functioning of kidneys contributing to the risk for kidney disorders
North America has the highest market share of 34.9% in the Kidney Function Test Market because of the existence of higher number of population facing kidney malfunctions and also due to the establishment of various major market players in this region
The major players of the market have been using inorganic methods for the purpose of growth and increase in the foothold in the market. One such instance has been the acquisition of Elucigene Diagnostics by Yourgene diagnostics, both being players in the molecular diagnostic methods in April 2019
The disposables that are used as a product for the purpose of Kidney Function Test have been growing as consumables and producing sector as well. The market share of these disposables is forecasted to be 35% and is seen to be growing in a positive trend

For the impetus of this study, Reports and Data have segmented the Global Kidney Function Test market on the basis of Products, Types, End-user and Regional outlook.

Product Type (Revenue, USD Million; 2016–2026)

Dipsticks
Reagents
Disposables

Type (Revenue, USD Million; 2016–2026)

Urine Tests
- Urine Protein Tests
- Creatinine Clearance Tests
- Micro albumin Tests
- Urinalysis
- Others
Blood Tests
- Serum Creatinine Tests
- Glomerular Filtration Rate Tests
- Blood Urea Nitrogen Tests
- Others
Kidney Biopsy
Imaging Tests
- Ultrasound
- Computed Tomography Scan
- Others
Dilution and Concentration Tests
Clearance Tests
Other Tests

End Use (Revenue, USD Million; 2016–2026)

Hospitals and Clinics
Diagnostic Laboratories
Research Laboratories and Institutes
Ambulatory Surgical Centres
Others

Regional Outlook (Revenue in USD Million; 2016–2026)

North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of the Europe
Asia Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
Middle East & Africa
Latin America

Brazil

Request for sample of this premium report at: https://www.reportsanddata.com/sample-enquiry-form/1448

Cannabis Based Beverages Market Recent Developments & Emerging Trends To 2026

Legalizing of recreational or medical cannabis, increased demand for wellness drinks, and vigorous technological and information exchange for legal marijuana is boosting the market for cannabis-based beverages.

Market Size – USD 1.57 Billion in 2018, Market Growth - CAGR of 15.4%, Market Trends –Increased use of cannabis for medicinal purpose.

The Global Cannabis based beverages Market is forecasted to reach USD 5.04 Billion by 2026, according to a new report by Reports and Data.

The market expansion of cannabis-based beverages has occurred due to a combination of various factors. One of the fundamental element in this context has been the initiative of legalizing the use of cannabis for medical usage in 30 countries. Apart from that, certain nations are taking action of legalizing the use of marijuana for recreational purpose. Such an initiative of legalizing the use of cannabis is acting as a significant driver for this market.

Apart from the mentioned driving factor, there has been an increase in use of cannabis in treating various health conditions like neurological disorders, psychiatric disorders, and cancer, and pain control. It is also observable that, consumers are having increased demand for wellness drinks. Such diverse applicability of cannabis results in having a significant positive impact on the demand for cannabis-based beverages, making a further contribution to its market growth. Major investors and key players of this industry are considering this area to be a lucrative market. As a result of this, they are increasing their investments in this market, which is also contributing to its growth.

In regards to region, North America is seen to be dominating the market because of its quick acceptance of this form of beverage, increased investment in healthcare and wellness sector and presence of consumers in this region who wants to experience smoke-free cannabis. A large amount of investment in R&D and mergers are also promoting the growth of this market in this region.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-cannabis-based-beverages-market

Further key findings from the report suggest

Other than legalizing the use of cannabis, its applicability in treating different health conditions, rise in private and public investment for R&D to promote a safer form of consuming marijuana is also acting as a driving factor for the market. The cannabis-based beverages market held a market share of USD 1.57 Billion in the year 2018 and is forecasted to grow at a rate of 15.4%.
The fact that this form of beverages contains clean ingredients, low sugar content, and the measured quantity of cannabis is also promoting the growth of the market.
In context to product type, the largest market share is held by the non-alcoholic segment that occupied 57% of the market share in 2018, and it is forecasted to witness a growth rate of 15.6% during the forecast period.
In the end user segment, Hotels, Restaurants and Café (HoReCa), holds the largest market share, and it is forecasted to maintain its market dominance. It is forecasted to hold 57% of the market share by 2026 with a CAGR of 15.1%. The reason for its market dominance is different regulations that regulate the consumption of cannabis beverages, which makes it difficult to be used in the household segment. Due to this, HoReCa gets an advantage in the market.
In context to the end user segment, the highest growth rate is forecasted to be witnessed by the household segment. Its high growth rate is because of the legalization of cannabis use for medical purpose. An initiative of legalizing cannabis for recreational use is forecasted to have a positive impact on this segment.
In the distribution channel segment, Business-to-consumers (B2C) holds the larger market segment of 53% in the year 2018. It is forecasted to witness a growth rate of 15.1%.
In the distribution channel, Business-to-business (B2B) is forecasted to witness the higher growth rate of 15.7% during the forecast period. It is because of the increased rate of investment in this industry that resulted in boosting the growth rate of this segment.
In the context of application, recreation holds the larger market segment, which is forecasted to hold 72% of the market share by 2026 with a CAGR of 15.2%. Factors like high availability of cannabis-based beverages for recreational purpose, an initiative of legalizing recreational use of marijuana resulted in its dominance in the market.
In regards to the component segment, Cannabidiol (CBD) dominates the market, which is forecasted to hold 56% of the market share by 2026. Increased preference for non-alcoholic cannabis beverages, in which Cannabidiol (CBD) is an integral element is what contributes to its market dominance.

Product Type Outlook (Revenue, USD Billion; 2016-2026)

Alcoholic
Cannabis-Infused Spirits
Cannabis-Infused Beers
Cannabis-Infused Wines
Others
Non-Alcoholic
Marijuana Elixirs
Marijuana Tea
Cannabis Soda
Cannabis Coffee and Cold Brew
Cannabis infused vitamin based energy water

End-user Outlook (Revenue, USD Billion; 2016-2026)

Household
Hotel/Restaurant/Café [HoReCa

Distribution channel Outlook (Revenue, USD Billion; 2016-2026)

B2B
B2C
Hypermarkets
Convenience Stores
Specialty Stores
Online Stores
Others

Application Outlook (Revenue, USD Billion; 2016-2026)

Medication
Recreation

Component Outlook (Revenue, USD Billion; 2016-2026)

Cannabidiol (CBD)
Tetrahydrocannabinol (THC)

Regional Outlook (Revenue, USD Billion; 2016-2026)

North America
- U,.S.
Europe
- UK
- France
Asia Pacific
- China
- India
- Japan
MEA
Latin America

Brazil

Request for FREE sample copy of this premium report at: https://www.reportsanddata.com/sample-enquiry-form/1434

Cervical Cancer Diagnostic Market Share, Size, Trends and In-Depth Analysis By 2026

High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario for development of cancer screening tests are key factors contributing to high CAGR of Cervical Cancer Diagnostic during forecast period.

Market Size – USD 6.81 Billion in 2018, Market Growth - CAGR of 6.2%. Market Trends – Product launches and research for Cardiac biomarkers.

According to the current analysis of Reports and Data, the global Cervical Cancer Diagnostic market was valued at USD 6.81 Billion in 2018 and is expected to reach USD 11.00 Billion by year 2026, at a CAGR of 6.2%.

According to the Centres for Disease Control and Prevention (CDC), six million people in the United States acquire HPV each year. At least 20 million already have it, and more than half of all sexually-active adults are expected to be infected during their lifetime. Cervical Cancer is a type of cancer which occurs in the lower part of the uterus which is connected to the vagina. Most of cervical cancer cases are caused by various strains of the human papillomavirus (HPV) which is a sexually transmitted infection. Vaginal bleeding, watery bloody discharge ad pelvic pain during intercourse are the symptoms of cervical cancer. Cervical Cancer can be diagnosed with the help of screening tests like Pap test, HPV DNA test, punch biopsy and endocervical curettage to treat two types of cancer i.e. Squamous cell cancers and Adenocarcinoma.

Increasing adoption of Pap test, huge amount of government funding, increase in occurrence of cervical cancer in middle age women which leads to increase in number of screening, and increase in awareness are some of the primary growth stimulants for the market. For instance, Medicaid, the popular government insurance program, covers the screening for cervical cancers. Medicare, another widely used insurance, covers Pap test, pelvic exam, and clinical breast exam for cervical cancer screening, every two years. These programs were found to be responsible for the growth of the overall market. Certain manufacturing and pharmacological issues and regulatory hurdles are hindering the growth of the market.

Increased FDA approval to companies is also propelling the growth of this market. For instance, in June 2018, FDA approved Bevacizumab (Avastin) of Genetech/Roche Inc plus chemotherapy for treating advanced cervical cancer patients.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-cervical-cancer-diagnostic-market

Further key findings from the report suggest:

Cervical Cancer Diagnostic market is fastest growing at a CAGR of 2% in Asia Pacific due to high awareness and access to modern healthcare infrastructure, low cost of VIA test and rise in consumption levels.
The market for point of care testing type segment is expected to hold the fastest growing CAGR because of increase in demand for speedy monitoring patients by doctors and clinicians.
Europe is the second largest region with a share of 25.8% due to the high cases of cervical disorders in France, Germany, and United Kingdom etc.
HPV Testing is accounted to be the second leading segment which holds a market share of 25.4% due to high usage for advanced diagnostics and cost effective procedures.
Diagnostic Centres segment is projected to have the highest CAGR among the other end user type.
North America is expected to account for the 45.6% of the global Cervical cancer Diagnostic market owing to the increasing occurrence of cervical cancer cases, rise in female population, growing acceptance of HPV infections along with government funding scenario.
Radiation Therapy segment holds the second largest share in this market which is valued at USD 2123.6 million due to its expensive manufacturing cost but people prefer it because it kills cancer cells at one go.
Key participants include Abbott Laboratories, Beckman Coulter, Becton, Dickinson and Company and F. Hoffmann-La Roche Ltd.

Segments covered in the report:

For the purpose of the study, this Reports and Data has segmented the Global Cervical Cancer Diagnostic Market on the basis of biomolecule type, disease type, profiling technologies, application, services and the regional outlook:

Product Type (Revenue, USD Million; 2016–2026)

Pap Smear Tests
Colposcopy
HPV Testing
Biopsy & Endocervical Curettage
Others

Therapy (Revenue, USD Million; 2016–2026)

Surgery
Radiation Therapy
Chemotherapy
Targeted Therapy

End User (Revenue, USD Million; 2016–2026)

Hospitals & Clinics
Diagnostic Centres
Laboratories
Others

Regional Outlook: (Revenue, USD Million; 2016–2026)

North America
- U.S.
- Canada

Europe
- Germany
- UK
- Spain
- France
- Italy
- Rest of Europe

Asia Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific

Latin America
- Brazil
- Mexico

Middle East and Africa (MEA)

Request for FREE sample copy of this premium report at: https://www.reportsanddata.com/sample-enquiry-form/1438

Abdominal Aortic Aneurysm Repair Device Market Size, Share, Trends, Companies, Application And Forecast To 2026

Rising prevalence of Abdominal Aortic Aneurysm due to rise in geriatric population and unhealthy living habits, new product launches, increasing strategic developments such as mergers and acquisitions, marketing techniques, favorable research funding scenario, adequate insurance coverage and reimbursements are key factors contributing to high CAGR of Abdominal Aortic Aneurysm Repair Device Market during forecast period.

Market Size – USD 2.11 Billion in 2018, Market Growth – 6.9%CAGR of Market Trends – Product launches and research in the field of Abdominal Aortic Aneurysm

According to the latest analysis by Reports and Data, it was found that Abdominal Aortic Aneurysm Repair Device market was valued at USD 2.11 billion in 2018 and is forecasted to attain a market value as high as USD 3.62 billion by 2026 at a CAGR of 6.9%. The study covers the analysis of the market for the devices utilized in the repair of a localized enlargement or bulging of the aorta situated in the lower abdominal area. This ailment is found to be most common among men rather than women. Smoking, consumption of alcohol, and unhealthy living habits are the risk factors involved in the occurrence of this ailment.

There are two major types of treatments involved- open surgery and methods like Endovascular Aneurysm Repair and laparoscopy which is minimal invasive in nature. Nowadays minimal invasive methods are chosen over opens surgeries as it takes minimal hospital time and easy recovery. Newer drugs and pharmacological methods are being evolved to fight the disorder.

The Abdominal Aortic Aneurysm Repair Device Market conditions are very found to be very favorable mostly due to the increase in people vulnerable to the disease or affected by it. This is due to the evolution of living habits that has called for the excessive use of tobacco and other substances including alcohol. This is also common among people who have a first degree relatives suffering from this ailment. Increase in disposable income and medical awareness among people has also acted as a driving force for the Abdominal Aortic Aneurysm Repair Device Market. Symptom are no longer treated as a natural pain by people. This helps in easy diagnosis and treatment, calling in for expansion of the market. Also exhaustive research is carried forward to introduce novel products and companies are involving in strategic acquisitions mergers and collaborations. But the market is not free from restraints. It is noticed that high cost of materials and medical expenditure has acted out as a hindrance to the Abdominal Aortic Aneurysm Repair Device Market. Apart from this low budget for medical expenses in LDCs, strict regulations by regulatory authorities for introduction of new products and monopolistic function act has an obstacle.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-abdominal-aortic-aneurysm-repair-device-market

Further Key Findings from the Abdominal Aortic Aneurysm Repair Device Market report

The rise in permissions, agreements and approvals given by the authorities in Asia-Pacific region makes it one of the most fast growing markets encouraging the introduction of new variants in the market. For example, the Japanese Ministry of Health, Labor and Welfare approve introduction of new products by Lombard Inc.
The North American market especially the US stretch holds the maximum amount of market share as it is the headquarters to a lot of primary players in the market like Boston Scientific Corp and Medtronic Plc.
Strategic partnerships and novel product launches were identified as the significant measures to capture market share. Microport Scientific corporation invested on Lombard Medical Inc. in order to gain exclusive product marketing rights by paying a lump sum amount of 15 million USD in 2016.
Smoking increase the risk of this disease by almost 50- 70%. Hence the largest market of the repair device is distributed among smokers. Also the risk is higher among women.
Endovascular aortic repair is preferred over open surgery as it is minimal invasive in characteristic and requires less hospital stay and recovery time make it increasingly popular.
Aortic graft stent has a tremendous market in hand due to the increasing cases of AAA and TAA diseases across the globe and it addresses complex anatomies.
The use of drugs, pharmacological measures are being exhaustively researched about. The micro management of the disease using MiRs is an upcoming highlighted topic for research.
Latin America is the most fast growing market due to the unrequited medical assistance in the field of aneurysm treatment.

Segmentation

This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the Abdominal Aortic Aneurysm Repair Device market on the basis of treatment, product type, anatomy, end user, and region:

Treatment (Revenue in USD Million; 2016–2026)

Open surgery
Endo vascular Aneurysm

Product Type (Revenue in USD Million; 2016–2026)

Stents
Catheters
Balloons
Wires
Others

End User (Revenue in USD Million; 2016–2026)

Hospitals
Clinics

Anatomy (Revenue in USD Million; 2016–2026)

Traditional Anatomy
Complex Anatomy

Regional Outlook (Revenue in USD Million; 2016–2026)

North America
- USA
- Canada
Europe
- UK
- France
- Germany
- Spain
- Italy
- Rest of Europe
Asia Pacific
- India
- China
- Japan
- Rest of Asia
Latin America

Brazil

Request for FREE sample copy of this premium report at: https://www.reportsanddata.com/sample-enquiry-form/1439

Atrial Fibrillation Market Upcoming Trends, Share & Insights Forecast To 2026

Increase in number of heart diseases coupled with technological advancements globally, are the major factors influencing market growth.

Market Size – USD 5.08 billion in 2018, Market Growth - CAGR of 14.1%, Market Trends –Technological advancement along with increasing heart diseases

The Atrial Fibrillation Market is estimated to reach USD 14.68 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the growing incidences of chronic heart diseases such as hypertension, obesity, and diabetes are leading to rising heart problems along with technological advancements that are expected to become the most common growth factors globally in the coming years.

Expanding efforts initiated by key companies for the development of advanced products will boost market growth. Also, the rising number of people suffering from high blood pressure and heart diseases are some of the common risks which are promoting need for advanced treatment. Atrial fibrillation (AF) is a kind of cardiac arrhythmia that is caused by unusual electrical activities in the atria. It can persist with no symptoms, but most common signs connected with it are palpitations, fainting, and chest pain. AF is confirmed by an electrocardiogram which presents an absence of the P wave and variable rate of ventricular contractions. These irregularities of the sino-atrial node in the regular cardio-electric impulses are the result of intervention from uncontrolled electric impulses causing from roots of pulmonary veins, consequently leading to the conduction of an irregular heartbeat. The most common type of arrhythmia is known as atrial fibrillation, according to WHO. Increasing prevalence of diseases such as hyperthyroidism, mitral stenosis, high blood pressure, pneumonia, pulmonary embolus, and obesity are one of the most significant triggering factors responsible for the high predominance of this disorder.

Due to the presence of key players, favorable reimbursement policies, and rising number of chronic diseases along with several initiatives initiated by the government, North America accounts for the largest share of 42.3% of the market in 2018.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-atrial-fibrillation-market

Further key findings from the report suggest

Growing population, increasing rates of heart diseases, and rising healthcare expenditure are the fundamental factors which are spurring the growth of the market across the globe.
EP ablation catheters of the product segment are estimated to reach USD 3.20 billion by 2026 at a CAGR of 14.1% during the forecast period.
Electrophysiology is a test to estimate the electrical activity of the heart and to diagnose atrial fibrillation or arrhythmia. Catheter ablation is a method implemented to treat some types of arrhythmia.
Due to its possible lucrativeness, several companies operating in the healthcare industry have widely adopted EP catheter ablation, making the market relatively fragmented and profoundly competitive.
Manufacturers are investing in research and development due to the rising demand for cost-effective procedures, and reliable imaging for implementing technologically advanced catheter ablation procedure.
An increasing number of hospitals are using a combination of both device and drugs to treat atrial fibrillation.
Innovative product development and collaborative developments are some critical strategic initiatives taken by the players in this industry to point their mark in the competition.
The presence of unique diagnostic and therapeutic medical technologies that enable quick and accurate diagnosis is a primary factor for the growth of this segment.
Cardiac monitors or implantable loop recorder product account for a market share of 20.6% in 2018.
Rising acceptance of cardiac monitors will augment industry growth in future years.
The adoption rate of cardiac monitors is growing due to effective long-term heart rhythm monitoring that it offers as compared to another standard electrocardiogram.
Moreover, the increasing demand for minimally invasive procedures is a major factor increasing the growth of the market.
The expanding application of such devices is mainly associated with current technological improvements including miniaturization, more accessible implant surgeries, and remote nursing, all of it making this procedure more promising and appealing.
Cardiac Centers end user is estimated to reach USD 4.60 billion by 2026 at the highest CAGR of 14.2% during the forecast period.
Europe accounts for a share of 23.2% in 2018 and is expected to grow at a rate of 14.1% during the forecast period.
Key participants include Abbott Laboratories, Atricure Inc., Johnson & Johnson, Microport Scientific Corporation, Boston Scientific Corporation, Biosense Webster, Inc., St. Jude medical, Inc., Siemens AG, Medtronic Plc, Koninklijke Philips N.V., Cardiofocus, Inc., Biotitic Se & Co. Kg, Inc., Carima, Inc., Ncontact, Inc., and Agricore, Inc.

For the purpose of this study, Reports and Data have segmented the global Atrial Fibrillation Market on the basis of Product, Application, End user and region:

Product Outlook (Revenue, USD Million; 2016-2026)

EP Ablation Catheters
Cardiac Monitors or Implantable Loop Recorder
EP Diagnostic Catheter
Mapping and Recording Systems
Access Devices
Intracardiac Echocardiography
Left Atrial Appendage Closure Devices

By Application Outlook (Revenue, USD Million; 2016-2026)

EP Ablation
Diagnostic
Surgical

By End-User Outlook (Revenue, USD Million; 2016-2026)

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Regional Outlook (Revenue, USD Million; 2016-2026)

North America
- U.S.
Europe
- France
- UK
Asia Pacific
- China
- India
- Japan
Latin America
- Brazil
MEA

Request for FREE sample copy of this premium report at: https://www.reportsanddata.com/sample-enquiry-form/1440

Pages

Tuesday, May 28, 2019

Intravenous Immunoglobulin (IVIG) Market Leading Player, Application & Forecast To 2026

Electroceuticals/Bioelectric Medicine Market Analysis, Growth, Trends, Challenges with Forecast To 2026

Kidney Function Test Market Trends, Emerging Growth Factors And Forecast 2026

Cannabis Based Beverages Market Recent Developments & Emerging Trends To 2026

Cervical Cancer Diagnostic Market Share, Size, Trends and In-Depth Analysis By 2026

Abdominal Aortic Aneurysm Repair Device Market Size, Share, Trends, Companies, Application And Forecast To 2026

Atrial Fibrillation Market Upcoming Trends, Share & Insights Forecast To 2026

The Alarming Increase in Incidences of Stroke is Boosting the Adoption of Neurovascular Devices